Skip to content

Lung Cancer Blog

Everything about lung cancer is here.

Menu
  • Home
  • About Us
  • Lung Cancer
    • Lung Cancer News
    • Causes of Lung Cancer
    • Lung Cancer Symptoms
    • Types of Lung Cancer
    • Stages of Lung Cancer
    • Lung Cancer Treatment
    • Lung Cancer Drugs
    • Lung Cancer In Ayurveda
    • Chinese Herbs For Lung Cancer
  • Researches
  • Studies
  • Stories
  • Sitemap
  • Contact Us
Menu
Second-Line Treatment for Lung Cancer

Second-Line Treatment for Lung Cancer

Posted on February 28, 2016
Post Views: 2,354

Second-Line Treatment for Lung CancerLung Cancer a dangerous disease but curable with proper guidance. As you regularly reading about lung cancer in this blogs previous posts, also you read about systemic therapy in “Systemic Therapy for Advance Non-Small Cell Lung Cancer” post. After that you read about First-Line treatment in previous post “First-Line Treatment for Lung Cancer”; now know about Second-Line and Third-Line Treatment.

Second-Line Treatment for Lung Cancer is a systemic therapy, in which drug or combination of drugs given to the patient after the failure of first-line treatment.

Following drugs options are suggested in second-line treatment patients with nonsquamous cell carcinoma:

  • Docetaxel (Docefrez, Taxotere): is an anti-mitotic chemotherapy drug that is clinically well-established that works by intrusive with cell division.
  • Erlotinib: known Tarceva as a trade name; is used to treat non-small cell lung cancer (NSCLC) by blocking Epidermal Growth Factor Receptor (EGFR) – EGFR is a protein which involved in growth and development of cancer.
  • Gefitinib: known Iressa as a trade name; it also block the growth of Epidermal Growth Factor Receptor (EGFR).
  • Pemetrexed: known Alimta as a trade name. This drug suggested to patients with nonsquamous cell carcinoma; not for patients with squamous cell carcinoma.

Following drugs options are suggested in second-line treatment patients with squamous cell carcinoma:

  • Docetaxel;
  • Erlotinib;
  • Gefitinib.

If first-line treatment with targeted therapy is failed to control the growth of cancer cells for patients with a genetic change to the EGFR gene, chemotherapy or other targeted therapy is recommended.

Patients with a genetic change to the ALK gene who’s cancer goes worse in first-line treatment, chemotherapy or ceritinib (Zykadia) are suggested.

If both first-line treatment and second-line treatment fails; also chemotherapy not recommended; third-line treatment suggested – read about it on post “Third-Line Treatment for Lung Cancer”.

This blog is only for providing information; please concern your doctor before starting any treatment. If he suggests you then only use that treatment. He knows well about your diseases and knows what best treatment for you.

Always follow your doctor!!!

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Tumblr (Opens in new window) Tumblr
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Telegram (Opens in new window) Telegram

Like this:

Like Loading...

Subscribe Us

Popular Articles

  • Lung Cancer Treatment in Ayurveda (7,303)
  • Lung Cancer: Symptoms and Treatment (5,625)
  • What is Non-Small-Cell Lung Cancer? (5,531)

Recent Comments

  • Lung Cancer on New Study To Help Advance Research In Lung Cancer
  • Laurie B Grimes on New Study To Help Advance Research In Lung Cancer
  • Lung Cancer on Asbestos and Lung Cancer – What’s The Link?

Recent Articles

  • FDA Grants Accelerated Approval to Telisotuzumab Vedotin-tllv for NSCLC May 19, 2025
  • Heart-Sparing Technique in Lung Cancer Radiotherapy May 12, 2025
  • Origins of Common Lung Cancer Linked to Smoking Discovered May 5, 2025
  • Lung Cancer Screening Is Beneficial For Non-Smokers As Well April 28, 2025
  • Understanding The Stage 0 Lung Cancer April 21, 2025

Lung Cancer Blog

Lung Cancer Blog provides all lung cancer related information for educational purposes.

Disclaimer

Some post may contain affiliate links, purchasing that product not going to cost extra but by your purchase Lung Cancer will get some little commission and that amount will help in surviving this website. So, please don’t hesitate to buy from these affiliate links.

Contact Us

If you have any query or suggestions about our blog, please feel free to email us at  lungcancersymptomsx@gmail.com.

Copyright © 2012 - 2025 Lung Cancer Blog. Wordpress by Vipasha.
%d